argenx SE reported $52.6B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AstraZeneca USD 178.16B 111.83B Aug/2026
Genmab DKK 126.96B 109.86B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Lakefront Biotherapeutics EUR 1.61B 115.98M Aug/2026
Qiagen NV USD 8.47B 396.81M Aug/2026
UCB EUR 46.41B 13.94B Dec/2025